85,281 Shares in HealthSouth Corporation (HLS) Acquired by Cornerstone Capital Management Holdings LLC.
Cornerstone Capital Management Holdings LLC. purchased a new stake in shares of HealthSouth Corporation (NYSE:HLS) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 85,281 shares of the company’s stock, valued at approximately $4,126,000. Cornerstone Capital Management Holdings LLC. owned 0.09% of HealthSouth Corporation at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. First Mercantile Trust Co. raised its position in HealthSouth Corporation by 18.8% during the second quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock valued at $132,000 after buying an additional 430 shares during the period. Acrospire Investment Management LLC raised its position in HealthSouth Corporation by 64.7% during the second quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock valued at $136,000 after buying an additional 1,100 shares during the period. Advisor Group Inc. raised its position in HealthSouth Corporation by 33.8% during the second quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock valued at $149,000 after buying an additional 781 shares during the period. Petrus Trust Company LTA acquired a new position in HealthSouth Corporation during the second quarter valued at $210,000. Finally, HL Financial Services LLC acquired a new position in HealthSouth Corporation during the second quarter valued at $213,000. 93.05% of the stock is currently owned by hedge funds and other institutional investors.
In other news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $43.00, for a total value of $972,875.00. Following the sale, the chief executive officer now directly owns 283,134 shares in the company, valued at $12,174,762. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.60% of the company’s stock.
HealthSouth Corporation (HLS) opened at 45.23 on Friday. The firm has a market capitalization of $4.47 billion, a price-to-earnings ratio of 16.48 and a beta of 0.58. HealthSouth Corporation has a 12 month low of $36.97 and a 12 month high of $49.71. The firm has a 50-day moving average price of $45.17 and a 200 day moving average price of $45.35.
HealthSouth Corporation (NYSE:HLS) last issued its quarterly earnings results on Monday, July 31st. The company reported $0.71 EPS for the quarter, beating analysts’ consensus estimates of $0.68 by $0.03. The company had revenue of $981.30 million for the quarter, compared to analyst estimates of $976.46 million. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.69 earnings per share. On average, equities analysts forecast that HealthSouth Corporation will post $2.71 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Monday, October 2nd will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.21%. This is a positive change from HealthSouth Corporation’s previous quarterly dividend of $0.24. The ex-dividend date is Friday, September 29th. HealthSouth Corporation’s payout ratio is 36.76%.
HLS has been the topic of several recent analyst reports. Zacks Investment Research lowered HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, August 15th. ValuEngine lowered HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. BidaskClub raised HealthSouth Corporation from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. KeyCorp reissued a “hold” rating on shares of HealthSouth Corporation in a research report on Thursday, September 7th. Finally, Royal Bank Of Canada reissued a “buy” rating and set a $55.00 price target on shares of HealthSouth Corporation in a research report on Wednesday, September 6th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $50.38.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).
Receive News & Stock Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related stocks with our FREE daily email newsletter.